Search for: "INTEGRA LIFESCIENCES I, LTD."
Results 1 - 20
of 22
Sorted by Relevance
|
Sort by Date
31 Jul 2007, 7:22 pm
Noonan -- The Federal Circuit decided the Integra Lifesciences I, Ltd. v. [read post]
14 Sep 2006, 3:30 am
Integra Lifesciences I. [read post]
15 Jan 2007, 12:20 pm
Integra Lifesciences I, Ltd., 125 S. [read post]
20 Apr 2005, 12:01 am
Integra Lifesciences I, Ltd. [read post]
12 Jan 2007, 6:20 pm
Integra Lifesciences I, Ltd.: Greater Research Protection for Drug Manufacturers, DJCLPP:See Lawrence Ebert, One Response to Merck v. [read post]
23 Sep 2008, 4:29 am
Integra Lifesciences I, Ltd., Microsoft Corp. v. [read post]
19 Aug 2008, 4:54 am
Integra Lifesciences I, Ltd., Microsoft Corp. v. [read post]
2 Aug 2007, 1:27 pm
Integra Lifesciences I, Ltd., 545 U.S. 193, 202 (2005). [read post]
27 Mar 2024, 4:46 pm
Integra Lifesciences I, Ltd., 545 U.S. 193 (2005). [read post]
26 Aug 2010, 4:05 am
Integra Lifesciences I, Ltd. [read post]
30 Jul 2007, 2:36 pm
" More detail of Integra Lifesciences I, Ltd. v. [read post]
3 Aug 2007, 3:36 pm
Integra Lifesciences I, Ltd., 125 S. [read post]
27 Feb 2018, 12:24 pm
" Integra Lifesciences I, Ltd. v. [read post]
3 May 2021, 1:48 pm
., Integra Lifesciences I, Ltd. v. [read post]
7 Aug 2012, 11:45 pm
Integra Lifesciences I, Ltd., 545 U.S. 193, 202 (2005) (citing Eli Lilly, 496 U.S. at 665-69). [read post]
11 Mar 2015, 9:40 am
Integra Lifesciences I, Ltd., 545 U.S. 193 (2005) (research exception to infringement) F.T.C. v. [read post]
13 Aug 2006, 2:24 pm
Integra LifeSciences I, Ltd., 125 S. [read post]
20 Mar 2008, 8:18 am
Integra Lifesciences I, Ltd., 545 U.S. 193 (2005) the Court explained that Congress intended that the immunity of regulatory activity not be inhibited, stating that "'271(e)(1)'s exemption from infringement extends to all uses of patented inventions that are reasonably related to the development and submission of any information under the FDCA. [read post]
26 Feb 2016, 1:21 pm
Integra Lifesciences I, Ltd., 545 U.S. 193 (2005): a unanimous Supreme Court ruled that the use of a patented compound in experiments that are not themselves included in a submission of information to the FDA does not, standing alone, render the use infringing. [read post]
27 Mar 2024, 10:56 am
In Edwards Lifesciences Corp. v. [read post]